Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | DNA polymerase eta, putative | 0.005 | 0.011 | 0.5 |
Loa Loa (eye worm) | RNA binding protein | 0.0064 | 0.1035 | 0.1035 |
Echinococcus multilocularis | geminin | 0.0172 | 0.7861 | 0.7861 |
Echinococcus multilocularis | cAMP specific 3',5' cyclic phosphodiesterase | 0.0205 | 1 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0064 | 0.1035 | 0.1035 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.005 | 0.011 | 0.0131 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.1035 | 0.1035 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.1035 | 0.1035 |
Echinococcus multilocularis | cAMP specific 3',5' cyclic phosphodiesterase | 0.0205 | 1 | 1 |
Giardia lamblia | CAMP-specific 3,5-cyclic phosphodiesterase 4B | 0.0205 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0104 | 0.354 | 0.354 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0064 | 0.1035 | 0.1035 |
Brugia malayi | RNA binding protein | 0.0064 | 0.1035 | 0.1231 |
Schistosoma mansoni | hypothetical protein | 0.0172 | 0.7861 | 0.7861 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0152 | 0.659 | 0.7834 |
Brugia malayi | Probable 3',5'-cyclic phosphodiesterase R153.1, putative | 0.018 | 0.8412 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.1035 | 0.1035 |
Schistosoma mansoni | hypothetical protein | 0.0104 | 0.354 | 0.354 |
Schistosoma mansoni | eyes absent homolog | 0.0098 | 0.317 | 0.317 |
Echinococcus granulosus | dna polymerase eta | 0.005 | 0.011 | 0.011 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0152 | 0.659 | 0.659 |
Brugia malayi | TAR-binding protein | 0.0064 | 0.1035 | 0.1231 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0104 | 0.354 | 0.4208 |
Echinococcus granulosus | cAMP specific 3'5' cyclic phosphodiesterase | 0.018 | 0.8412 | 0.8412 |
Leishmania major | DNA polymerase eta, putative | 0.005 | 0.011 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0098 | 0.317 | 0.317 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.1035 | 0.1035 |
Schistosoma mansoni | hypothetical protein | 0.0172 | 0.7861 | 0.7861 |
Loa Loa (eye worm) | hypothetical protein | 0.0205 | 1 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0152 | 0.659 | 0.7834 |
Echinococcus multilocularis | cAMP specific 3',5' cyclic phosphodiesterase | 0.018 | 0.8412 | 0.8412 |
Echinococcus granulosus | geminin | 0.0172 | 0.7861 | 0.7861 |
Echinococcus granulosus | cAMP specific 3'5' cyclic phosphodiesterase | 0.0205 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0098 | 0.317 | 0.3769 |
Schistosoma mansoni | camp-specific 35-cyclic phosphodiesterase | 0.0205 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0098 | 0.317 | 0.317 |
Loa Loa (eye worm) | TAR-binding protein | 0.0064 | 0.1035 | 0.1035 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0064 | 0.1035 | 0.1231 |
Toxoplasma gondii | 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein | 0.0205 | 1 | 0.5 |
Echinococcus granulosus | tar DNA binding protein | 0.0064 | 0.1035 | 0.1035 |
Loa Loa (eye worm) | cyclic AMP specific phosphodiesterase PDE4D5A | 0.018 | 0.8412 | 0.8412 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.005 | 0.011 | 0.5 |
Echinococcus multilocularis | dna polymerase eta | 0.005 | 0.011 | 0.011 |
Loa Loa (eye worm) | hypothetical protein | 0.0152 | 0.659 | 0.659 |
Schistosoma mansoni | DNA polymerase eta | 0.005 | 0.011 | 0.011 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.1035 | 0.1035 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.011 | 0.011 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.